Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Clinical trial NCT06714123 · RECRUITING

Trial details

NCT number: NCT06714123
Sponsor: Vejle Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Fibrosis, Interstitial Lung Disease Idiopathic Pulmonary Fibrosis

Start date: 2025-08-01
Primary completion: 2028-12-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.